Part 3 of this 6part CMECEcertified Medical Minute series identifies how social determinants of health in the use of LAI antipsychotics affect the care received through examination of evidence about use of firstgeneration and secondgeneration LAI antipsychotics across racial and ethnic groups and other barriers to LAI antipsychotic use
- Provider:Clinical Care Options
- Activity Link: https://clinicaloptions.com/CE-CME/neurology/lai-mm3-2024/25076-48059
- Start Date: 2024-08-21 05:00:00
- End Date: 2024-08-21 05:00:00
- Credit Details: IPCE Credits: 0.25 hours
AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - Commercial Support: Source: Indivior Inc - Amount: 2272.72 - Is Kind Support: False Source: Otsuka America Pharmaceutical, Inc. - Amount: 4545.45 - Is Kind Support: False Source: Teva Pharmaceutical Industries - Amount: 22727.27 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest